CLINICAL OUTCOMES IN PATIENTS WITH SEVERE ASTHMA WHO HAD OR HAD NOT INITIATED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY

Autor: NASLOON ALI, STEPHANIE CHEN, TRUNG N TRAN, WILLIAM COOK, ALAN ALTRAJA, ARNAUD AB BOURDIN, CHAU-CHYUN SHEU, MING-JU TSAI, FLAVIA C HOYTE, ANNA R QUINTON, BENJAMIN EMMANUEL, CELINE GOH, VICTORIA CARTER, DAVID B PRICE

Publikováno v: Chest. 162:A28-A32

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbe8f90cf861ca626099e32fed443356
https://doi.org/10.1016/j.chest.2022.08.020

Comparative effectiveness of Anti‐IL5 and Anti‐IgE biologic classes in patients with severe asthma eligible for both

Autor: Paul E. Pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik, Trung N. Tran, Jorge Maspero, Matthew Peters, George C. Christoff, Mohsen Sadatsafavi, Carlos A. Torres‐Duque, Alan Altraja, Lauri Lehtimäki, Nikolaos G. Papadopoulos, Sundeep Salvi, Richard W. Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al‐Ahmad, Désirée Larenas‐Linnemann, Piotr Kuna, João A. Fonseca, Riyad Al‐Lehebi, Chin Kook Rhee, Luis Perez‐de‐Llano, Diahn‐Warng Perng Steve, Bassam Mahboub, Eileen Wang, Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Andrey S. Belevskiy, Mohit Bhutani, Leif Bjermer, Unnur Bjornsdottir, Arnaud Bourdin, Anna von Bulow, John Busby, Giorgio Walter Canonica, Borja G. Cosio, Delbert R. Dorscheid, Mariana Muñoz‐Esquerre, J. Mark FitzGerald, Esther Garcia Gil, Peter G. Gibson, Liam G. Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David J. Jackson, Mariko Siyue Koh, Hsin‐Kuo Bruce Ko, Jae Ha Lee, Sverre Lehmann, Cláudia Chaves Loureiro, Dóra Lúðvíksdóttir, Andrew N. Menzies‐Gow, Patrick Mitchell, Andriana I. Papaioannou, Todor A. Popov, Celeste M. Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taillé, Christian Taube, Yuji Tohda, Michael E. Wechsler, David B. Price

Publikováno v: Pfeffer, P E, Ali, N, Murray, R, Ulrik, C, Tran, T N, Maspero, J, Peters, M, Christoff, G C, Sadatsafavi, M, Torres-Duque, C A, Altraja, A, Lehtimäki, L, Papadopoulos, NG, Salvi, S, Costello, R W, Cushen, B, Heffler, E, Iwanaga, T, Al-Ahmad, M, Larenas-Linnemann, D, Kuna, P, Fonseca, J A, Al-Lehebi, R, Rhee, C K, Perez-de-Llano, L, Perng Steve, D W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Newell, A, Alacqua, M, Belevskiy, A S, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, A V, Busby, J, Canonica, G W, Cosio, B G, Dorscheid, D R, Muñoz-Esquerre, M, FitzGerald, J M, Gil, E G, Gibson, P G, Heaney, L G, Hew, M, Hilberg, O, Hoyte, F, Jackson, D J, Koh, M S, Ko, H K B, Lee, J H, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, A N, Mitchell, P, Papaioannou, A I, Popov, T A, Porsbjerg, C M, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, M E & Price, D B 2023, ' Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 78, no. 7, pp. 1934-1948 . https://doi.org/10.1111/all.15711

BackgroundPatients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of adult patients with severe asthma eligible fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b470f5130538493695eea0718adb81
https://doi.org/10.1111/all.15711

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both

Autor: David Price, paul pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik, Trung Tran, Jorge Maspero, Matthew Peters, George Christoff, Mohsen Sadatsafavi, Carlos A. Torres-Duque, Alan Altraja, Lauri Lehtimäki, Nikolaos Papadopoulos, Sundeep Salvi, Richard W. Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al-Ahmad, Désirée Larenas-Linnemann, Piotr Kuna, João Fonseca, Riyad Al-Lehebi, Chin Kook Rhee, Luis Perez de Llano, Diahn-Wang Perng, Bassam Mahboub, Eileen Wang, Yun Yi Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Mohit Bhutani, Leif Bjermer, Unnur Steina Björnsdóttir, Arnaud Bourdin, Anna Von Bülow, John Busby, Walter Canonica, Borja G Cosio, Delbert Dorscheid, Mariana Muñoz Esquerre, Mark FitzGerald, Esther Garcia Gil, Peter Gerard Gibson, Liam Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David Jackson, Mariko Koh, Hsin-Kuo Ko, Jae Ha Lee, Sverre Lehmann, Claudia Chaves Loureiro, Dora Ludviksdottir, Andrew Menzies-Gow, Patrick Mitchell, Andriana Papaioannou, Todor Popov, Celeste Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taillé, Christian Taube, Yuji Tohda, M. E. Wechsler

Background Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of severe adult asthma patients eligible for bo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bdb3674b6c9eff50aa949ab5d85a483b
https://doi.org/10.22541/au.166563547.79282253/v1